Another gene therapy death of a Duchenne patient has some parents and doctors criticizing the FDA's actions, even as other ...

A federal judge ruled that some of the grant terminations by the National Institutes of Health on DEI grounds are “void and ...

Following a turbulent few years, Sage Therapeutics has been acquired by Maryland-based Supernus Pharmaceuticals for up to ...

A private equity firm will finance a Harvard University research lab, a possible template for the future as schools ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

The links between ultra-processed food and higher risk of diabetes will be the focus of the first wave of Kennedy’s national ...

Supernus Pharmaceuticals said it is acquiring Sage Therapeutics, the distressed maker of a drug for postpartum depression, ...

An IVF doctor and clinic founder writes that his industry needs increased governmental oversight and more comprehensive ...

The law shouldn’t force pregnant people to assume greater duties to their fetuses than parents have to their children.

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death ...

The playbooks are designed to create a roadmap and offer guidance for more than 80% of U.S. health care organizations and ...